FLASHFER™ PLUS

FLASHFER™ PLUS represents the premium tier of iron supplementation — using Ferrous Bis-Glycinate, the most advanced and bioavailable oral iron formulation currently available.

Ferrous Bis-Glycinate (Iron Chelate): In bis-glycinate, ferrous iron is chelated with two glycine molecules — forming a stable, electrically neutral chelate that is absorbed through a completely different intestinal transporter than conventional ionic iron. While ferrous sulphate and ferrous ascorbate are absorbed through DMT1 (divalent metal transporter-1, which requires ferrous state maintenance), ferrous bis-glycinate is absorbed intact through the peptide transporter PepT1 — the same transporter used for dipeptides and certain amino acids. This alternative absorption route provides three critical advantages: the chelate bypasses the competition with other divalent cations (calcium, zinc, magnesium) that reduces conventional iron absorption, it is absorbed without requiring gastric acid (suitable for hypochlorhydric patients), and it causes virtually no GI side effects because the iron is never in free ionic form in the GI lumen — the glycinate chelate reaches the enterocyte intact before releasing iron intracellularly.

The result is bioavailability 2–4× higher than ferrous sulphate, with essentially zero GI side effects — no nausea, no constipation, no black stool — enabling reliable compliance throughout long treatment courses.

Zinc Bis-Glycinate uses the same chelate technology for zinc — providing high-bioavailability zinc via PepT1 that doesn't compete with iron for absorption (unlike conventional zinc sulphate + iron sulphate combinations where the two metals competitively inhibit each other's DMT1-mediated absorption). The bis-glycinate chelate eliminates this competition.

Vitamin C, Folic Acid, and Vitamin B12 provide the complete haematopoietic nutrient complex — vitamin C maintains ferrous state and enhances enterocyte iron release from the chelate, folate enables erythroid precursor DNA replication, and B12 is required for megaloblastic anaemia prevention and myelin synthesis.

Iron deficiency anaemia in all patient groups where conventional iron is poorly tolerated or ineffective — including inflammatory bowel disease (where mucosal inflammation reduces conventional iron absorption), elderly with reduced gastric acid, patients on PPIs, women with significant iron-associated nausea that causes non-compliance with standard iron supplements, competitive athletes (iron loss through haemolysis and sweating), and patients with coexisting zinc deficiency (the most common mineral deficiency co-occurring with IDA). Also indicated for IDA in diabetic patients where the simultaneous iron-zinc bis-glycinate combination addresses the dual micronutrient deficiency common in this population.

Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.